Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation
- PMID: 27989013
- PMCID: PMC5445007
- DOI: 10.1111/ajt.14169
Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation
Abstract
The Immune Development in Pediatric Transplantation (IMPACT) study was conducted to evaluate relationships among alloimmunity, protective immunity, immune development, physical parameters, and clinical outcome in children undergoing kidney transplantation. We prospectively evaluated biopsy-proven acute rejection (BPAR), de novo donor-specific antibody (dnDSA) formation, viremia, viral infection, T cell immunophenotyping, and body mass index (BMI)/weight Z scores in the first year posttransplantation in 106 pediatric kidney transplant recipients. Outcomes were excellent with no deaths and 98% graft survival. Rejection and dnDSAs occurred in 24% and 22%, respectively. Pretransplant cytomegalovirus (CMV) and Epstein-Barr virus (EBV) serologies and subsequent viremia were unrelated to BPAR or dnDSA. Viremia occurred in 73% of children (EBV, 34%; CMV, 23%; BMK viremia, 23%; and JC virus, 21%). Memory lymphocyte phenotype at baseline was not predictive of alloimmune complications. Patients who developed viral infection had lower weight (-2.1) (p = 0.028) and BMI (-1.2) (p = 0.048) Z scores at transplantation. The weight difference persisted to 12 months compared with patients without infection (p = 0.038). These data indicate that there is a high prevalence of viral disease after pediatric kidney transplantation, and underweight status at transplantation appears to be a risk factor for subsequent viral infection. The occurrence of viremia/viral infection is not associated with alloimmune events.
Keywords: clinical research/practice; infection and infectious agents; kidney transplantation/nephrology; nutrition; pediatrics; rejection; translational research/science; viral.
© 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.
Figures




Similar articles
-
Effect of early EBV and/or CMV viremia on graft function and acute cellular rejection in pediatric liver transplantation.Clin Transplant. 2012 Jan-Feb;26(1):E55-61. doi: 10.1111/j.1399-0012.2011.01535.x. Epub 2011 Oct 10. Clin Transplant. 2012. PMID: 21981027
-
The simultaneous presence of active BK, Epstein Barr, and human cytomegalovirus infection and their correlation by host factors in patients suspected of kidney transplant rejection.BMC Infect Dis. 2024 Sep 9;24(1):937. doi: 10.1186/s12879-024-09821-z. BMC Infect Dis. 2024. PMID: 39251898 Free PMC article.
-
Primary Cytomegalovirus Infection Significantly Impacts Circulating T Cells in Kidney Transplant Recipients.Am J Transplant. 2015 Dec;15(12):3143-56. doi: 10.1111/ajt.13396. Epub 2015 Jul 24. Am J Transplant. 2015. PMID: 26211927
-
Epstein-Barr virus and renal transplantation.Transplant Rev (Orlando). 2017 Jan;31(1):55-60. doi: 10.1016/j.trre.2016.12.001. Epub 2016 Dec 29. Transplant Rev (Orlando). 2017. PMID: 28089555 Review.
-
Epidemiology and Risk Factors for Viral Infections in Pediatric Liver Transplant Recipients and Impact on Outcome.Viruses. 2023 Apr 26;15(5):1059. doi: 10.3390/v15051059. Viruses. 2023. PMID: 37243144 Free PMC article. Review.
Cited by
-
Relationship between antithymocyte globulin, T cell phenotypes, and clinical outcomes in pediatric kidney transplantation.Am J Transplant. 2021 Feb;21(2):766-775. doi: 10.1111/ajt.16263. Epub 2020 Sep 12. Am J Transplant. 2021. PMID: 33480466 Free PMC article.
-
Incidence, risk factors, management strategies, and outcomes of antibody-mediated rejection in pediatric kidney transplant recipients-a multicenter analysis of the Cooperative European Paediatric Renal Transplant Initiative (CERTAIN).Pediatr Nephrol. 2025 Feb;40(2):491-503. doi: 10.1007/s00467-024-06487-2. Epub 2024 Sep 16. Pediatr Nephrol. 2025. PMID: 39283519 Free PMC article.
-
Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the "Net State of Immunosuppression".Clin Infect Dis. 2021 Oct 5;73(7):e1302-e1317. doi: 10.1093/cid/ciaa1189. Clin Infect Dis. 2021. PMID: 32803228 Free PMC article. Review.
-
Malnutrition and immune cell subsets in children undergoing kidney transplantation.Pediatr Transplant. 2022 Dec;26(8):e14371. doi: 10.1111/petr.14371. Epub 2022 Aug 8. Pediatr Transplant. 2022. PMID: 35938682 Free PMC article.
-
Debates in Management and Treatment of CMV in Pediatric Solid Organ Transplant Recipients: A Case-Based Discussion.Pediatr Transplant. 2025 Aug;29(5):e70135. doi: 10.1111/petr.70135. Pediatr Transplant. 2025. PMID: 40671272 Free PMC article. Review.
References
-
- Dharnidharka VR, Fiorina P, Harmon WE. Kidney transplantation in children. N Engl J Med. 2014;371(6):549–558. - PubMed
-
- Matas AJ, Smith JM, Skeans MA, Thompson B, Gustafson SK, Stewart DE, et al. OPTN/SRTR 2013 Annual Data Report: kidney. Am J Transplant. 2015;15(Suppl 2):1–34. - PubMed
-
- Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401(6754):708–712. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical